 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 07/10/2025 |
$21.57 |
$22.12 |
$21.37 |
$22.06 |
1.47M | | 07/11/2025 |
$21.96 |
$22.14 |
$20.97 |
$20.98 |
2.08M | | 07/14/2025 |
$20.93 |
$21.92 |
$20.87 |
$21.89 |
1.63M | | 07/15/2025 |
$21.94 |
$22.26 |
$21.76 |
$22.01 |
2.57M | | 07/16/2025 |
$22.08 |
$22.62 |
$21.96 |
$22.55 |
2.09M |
|
|
| Acadia Pharmaceuticals Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. | |
|
Acadia Pharmaceuticals (ACAD) has the following price history information. Looking back at ACAD historical stock prices for the last five trading days, on July 10, 2025, ACAD opened at $21.57, traded as high as $22.12 and as low as $21.37, and closed at $22.06. Trading volume was a total of 1.47M shares. On July 11, 2025, ACAD opened at $21.96, traded as high as $22.14 and as low as $20.97, and closed at $20.98. Trading volume was a total of 2.08M shares. On July 14, 2025, ACAD opened at $20.93, traded as high as $21.92 and as low as $20.87, and closed at $21.89. Trading volume was a total of 1.63M shares. On July 15, 2025, ACAD opened at $21.94, traded as high as $22.26 and as low as $21.76, and closed at $22.01. Trading volume was a total of 2.57M shares. On July 16, 2025, ACAD opened at $22.08, traded as high as $22.62 and as low as $21.96, and closed at $22.55. Trading volume was a total of 2.09M shares.
ACAD Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acadia Pharmaceuticals shares, starting with a $10,000 purchase of ACAD, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
07/20/2015 |
|
| End date: |
07/16/2025 |
|
| Start price/share: |
$49.79 |
|
| End price/share: |
$22.55 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-54.71% |
|
| Average Annual Total Return: |
-7.62% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,527.66 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 07/10/2025 | $22.06 | | 07/11/2025 | $20.98 | | 07/14/2025 | $21.89 | | 07/15/2025 | $22.01 | | 07/16/2025 | $22.55 |
|
|
Free ACAD Email Alerts:
